What FDA PDUFA VII Performance Goals and Procedures 2023-2027 requires
The FDA PDUFA VII requires prescription drug manufacturers to meet specific performance goals and procedures…
This is a preview. The full record adds the complete summary, 10 workflow steps, 10 schema fields and 6 primary citations. Start a free trial or see pricing.
Pillar: Pharmaceuticals & Life Sciences · Authority: U.S. Food and Drug Administration · Version: 1.0.1 · Last updated:
Primary source: https://www.fda.gov/industry/prescription-drug-user-fee-amendments/pdufa-vii-fiscal-years-2023-2027
SHA-256 integrity: 49e66ac98a0a32458e3c8011c3f6334c14060a04ed25af0d4116c5b6dba1c4ba
Primary Citations — 6 traced to source
- Federal Food, Drug, and Cosmetic Act, Section 735(1)
- PDUFA VII Performance Goals and Procedures 2023-2027, Goal 1: Review Timelines
+ 4 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/fda-pdufa-vii-goals-letter-2022.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/fda-pdufa-vii-goals-letter-2022.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/fda-pdufa-vii-goals-letter-2022
- Back to registry: Browse all 10,102 compliance nodes